Kestrel Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
VPM
VCM
Kestrel Investment Management's PBH Position: Q1 2026 in Review
Kestrel Investment Management reduced its Prestige Consumer Healthcare (PBH) stake by 0.57% in Q1 2026, selling an estimated $26K and leaving 70,050 shares worth $4.15M. The position accounts for 2.48% of the portfolio, ranked #20.
Kestrel Investment Management first reported a position in PBH in Q3 2018 and has held it in 23 quarters since. The position peaked at $8.3M in Q2 2021. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.
- Kestrel Investment Management held 70,050 shares of Prestige Consumer Healthcare worth $4.15M as of Q1 2026.
- Kestrel Investment Management sold 400 Prestige Consumer Healthcare shares in Q1 2026, an estimated $26K.
- Prestige Consumer Healthcare made up 2.48% of Kestrel Investment Management's portfolio in Q1 2026, its #20 holding.
- Kestrel Investment Management first reported a position in Prestige Consumer Healthcare in Q3 2018 and has held it in 23 quarters since.
- Kestrel Investment Management's Prestige Consumer Healthcare position peaked at $8.3M in Q2 2021.
- 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.
Based on Kestrel Investment Management's 13F filing for Q1 2026, filed 5 May 2026.